HomeCompareASEPF vs JNJ

ASEPF vs JNJ: Dividend Comparison 2026

ASEPF yields 38.76% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASEPF wins by $196.6K in total portfolio value
10 years
ASEPF
ASEPF
● Live price
38.76%
Share price
$5.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$216.7K
Annual income
$35,663.89
Full ASEPF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ASEPF vs JNJ

📍 ASEPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASEPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASEPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASEPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASEPF
Annual income on $10K today (after 15% tax)
$3,294.57/yr
After 10yr DRIP, annual income (after tax)
$30,314.31/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ASEPF beats the other by $29,610.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASEPF + JNJ for your $10,000?

ASEPF: 50%JNJ: 50%
100% JNJ50/50100% ASEPF
Portfolio after 10yr
$118.3K
Annual income
$18,245.84/yr
Blended yield
15.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ASEPF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASEPF buys
0
JNJ buys
0
No recent congressional trades found for ASEPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASEPFJNJ
Forward yield38.76%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$216.7K$20.0K
Annual income after 10y$35,663.89$827.78
Total dividends collected$161.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ASEPF vs JNJ ($10,000, DRIP)

YearASEPF PortfolioASEPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$14,576$3,875.97$10,676$355.77+$3.9KASEPF
2$20,876$5,280.00$11,407$389.39+$9.5KASEPF
3$29,405$7,067.50$12,198$426.53+$17.2KASEPF
4$40,767$9,303.62$13,056$467.62+$27.7KASEPF
5$55,675$12,054.66$13,987$513.12+$41.7KASEPF
6$74,959$15,385.99$14,998$563.56+$60.0KASEPF
7$99,566$19,359.76$16,098$619.52+$83.5KASEPF
8$130,568$24,032.74$17,295$681.69+$113.3KASEPF
9$169,162$29,454.16$18,599$750.82+$150.6KASEPF
10$216,667$35,663.89$20,022$827.78+$196.6KASEPF

ASEPF vs JNJ: Complete Analysis 2026

ASEPFStock

Alpine Summit Energy Partners, Inc. operates as an energy developer in the United States. It has various oil and gas assets in the Austin Chalk and Eagle Ford formations in the Giddings Field near Austin, Texas. The company was founded in 2018 and is headquartered in Nashville, Tennessee.

Full ASEPF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ASEPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASEPF vs SCHDASEPF vs JEPIASEPF vs OASEPF vs KOASEPF vs MAINASEPF vs ABBVASEPF vs MRKASEPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.